Oklahoma Tobacco Settlement Endowment Trust
Oklahoma Tobacco Settlement Endowment Trust: what it invests in
Geography Mainly domestic
Oklahoma Tobacco Settlement Endowment Trust: how big it is, and on what basis
In US dollars: about USD 1.72B. Fund reports in US dollars
Oklahoma Tobacco Settlement Endowment Trust: what it publishes
Published 5 · Partly 1 · Not published 4
Our 10 item score. It measures what is public, not how well a fund is run.
At a glance. TSET is Oklahoma's constitutional endowment built from tobacco settlement payments. Its USD 1.72 billion corpus is invested by a Board of Investors, and only the earnings are spent, on grants that fight tobacco use and obesity and so reduce cancer and heart disease. It has put about USD 1 billion into Oklahomans' health since 2000, including USD 150 million of Legacy Grants in 2025. S1 S3
Key points
- Corpus balance of USD 1.72 billion at 30 June 2025. S1
- Receives 75 percent of each settlement payment: USD 44.2 million of USD 58.9 million in 2025. S1
- Only investment earnings are spent; the fiscal 2025 grant and programme budget was USD 82.1 million. S1
- Budget split: tobacco prevention 35 percent, obesity prevention 21 percent, research 17 percent, emerging opportunities 16 percent. S1
- Awarded USD 150 million of Legacy Grants in November 2025. S3
- Two boards: five investors chaired by the State Treasurer, and seven directors who award the grants. S1
Interesting facts
Mandate and goals
Reduce Oklahoma's leading causes of preventable death, tobacco use and obesity, to cut cancer and cardiovascular disease, using only the endowment's earnings. S1
How it invests
| Industries | Healthcare and life sciences S1 |
|---|---|
| Asset classes | Not published S1 |
| Stages | Not published S1 |
| Geography | Mainly domestic. Grants are made across Oklahoma; portfolio geography not published S1 |
| Direct / through funds / co-invest | Not published / Not published / No S1 |
| Ticket size | Grant sizes vary by programme; no investment ticket is published. S1 |
| Deal sizes seen | USD 1.7M (screening bus) to USD 150M (Legacy Grants) |
| External managers | Not published S1 |
| Co-investment programme | None S1 |
Published criteria
Past investments
| Year | Investment | Type | Sector | Amount |
|---|---|---|---|---|
| 2025 | Legacy Grants. Large health grants awarded in November 2025. S3 | Direct investment | Healthcare and life sciences | USD 150M |
| 2025 | Mobile lung cancer screening bus. Launched February 2025 to screen across the state. S1 | Direct investment | Healthcare and life sciences | USD 1.7M |
| 2017 | TSET Phase 1 Program. Early clinical trials programme. S1 | Direct investment | Healthcare and life sciences | Not published |
| 2015 | TSET Healthy Living Program. Community grants that helped pass over 1,500 health policies. S1 | Direct investment | Healthcare and life sciences | USD 14M |
| 2012 | Healthy Incentive Grants. Grants to schools and communities. S1 | Direct investment | Healthcare and life sciences | About USD 10M to date |
| 2011 | Physician Loan Repayment Program. Rural physician placement; over 667,000 patient visits. S1 | Direct investment | Healthcare and life sciences | Not published |
| 2009 | Oklahoma Center for Adult Stem Cell Research. Research centre set up by TSET. S1 | New company or platform | Healthcare and life sciences | Not published |
| 2003 | Oklahoma Tobacco Helpline. Flagship free cessation service; nearly 30,000 registrations in fiscal 2025. S1 | New company or platform | Healthcare and life sciences | Not published |
Case studies
The Oklahoma Tobacco Helpline S1
- What: TSET launched a free statewide quit line, later adding free nicotine replacement products.
- When: Since 2003
- Size: Not published
- Why: Tobacco use was the state's leading cause of preventable death.
- Outcome: Adult smoking fell from 28.6 to 14.1 percent (2001 to 2024); 45.4 percent quit rate in fiscal 2025.
Research that attracts more funding S1
- What: Grants to research centres such as Stephenson Cancer Center and an adult stem cell centre.
- When: 2007 onwards
- Size: Not published
- Why: To build Oklahoma's research base in cancer and chronic disease.
- Outcome: Over USD 855M of additional funding leveraged.
Investment process
The Board of Investors, chaired by the State Treasurer, invests the corpus. The bipartisan Board of Directors, named by seven appointing authorities, allocates earnings to grants and programmes. S1
| Committee | Role |
|---|---|
| Board of Investors | Five members chaired by the State Treasurer; invests the fund S1 |
| Board of Directors | Seven members; awards grants from earnings S1 |
- Settlement payments are split and 75 percent is deposited. S1
- The Board of Investors invests the corpus. S1
- Earnings fund an annual grant budget. S1
- Directors award grants through published programmes. S1
How to approach: Grant applicants use TSET's published grant programmes; there is no investment intake. S3
Size and returns
- Headline size: USD 1.72B (Fund market value, as of 2025-06-30) S1
- In US dollars: about USD 1.72B. Fund reports in US dollars
- Invested in health since inception: About USD 1B (Committed or authorised capital) S3
- Returns: the fund does not publish a return figure.
- Size over time (USD billion): June 2025 1.72 S1
Leadership
| Name | Title | Since |
|---|---|---|
| J. Lance Thomas | Interim Executive Director S5 | 2026-04 |
| Kenneth Rowe, CPA | Chair, Board of Directors S1 | Not published |
| Jennifer Needham, J.D. | Vice Chair, Board of Directors S1 | Not published |
| Todd Russ | Chair, Board of Investors; State Treasurer S1 | Not published |
| Deborah Mueggenborg, CPA | Vice Chair, Board of Investors S1 | Not published |
Governance and transparency
- Legal basis: Oklahoma Constitution, amendment approved by voters in 2000 S1
- Oversight: Two constitutional boards; audited annual statements S1
- Directors are bipartisan and represent each congressional district. S1
Transparency score: 5.5 of 10 (band 3 of 5). Our own 10-item rubric; see the methodology page.
History
| Date | Event |
|---|---|
| 1998-11 | Master Settlement Agreement signed by 46 states. S1 |
| 2000-11 | Voters create TSET. S1 |
| 2001 | Board of Directors first meets; first deposits. S1 |
| 2003 | Oklahoma Tobacco Helpline launched. S1 |
| 2009 | Adult stem cell research centre set up. S1 |
| 2015 | Healthy Living Program launched. S1 |
| 2017 | Phase 1 clinical trials programme. S1 |
| 2025-04-01 | 25th anniversary begins. S1 |
| 2025-11 | USD 150M Legacy Grants. S3 |
| 2026-04 | Interim Executive Director appointed. S5 |
For family offices
A state health endowment that spends only its earnings on grants. It has no co-investment programme; its relevance is as a long-term public endowment investor. S1
Reports
Common questions
How big is TSET?
USD 1.72 billion corpus at 30 June 2025. S1
Where does the money come from?
75 percent of Oklahoma's tobacco settlement payments. S1
Who invests it?
A Board of Investors chaired by the State Treasurer, Todd Russ. S1
Who leads TSET?
J. Lance Thomas, Interim Executive Director since April 2026. S5
Related profiles
- Alaska Permanent Fund United States (Alaska) · USD 91.9B
- New Mexico State Investment Council (SIC) United States (New Mexico) · USD 74.63B
- Texas Permanent School Fund United States (Texas) · USD 60.6B
- Texas Permanent University Fund (PUF) United States (Texas) · USD 40.29B
- Alberta Heritage Savings Trust Fund Canada (Alberta) · C$31.9B
- North Dakota Legacy Fund United States (North Dakota) · USD 15.10B
All sovereign wealth funds in North America · All sub-national permanent funds · All funds in United States
Sources
Disclaimer
Informational only. SovereignWealthFunds.com is an independent public-source reference. It is not affiliated with or endorsed by any fund named on it, and it is not investment, legal or tax advice. Figures are as of the dates shown next to them and may have changed; please read each fund's official pages, linked on its profile. To report an error, use the contact page. Copyright SovereignWealthFunds.com. All rights reserved.
